FORT LAUDERDALE, Fla.--(BW HealthWire)--Nov. 18, 1999--
Invision International, Inc., a privately held firm, has made arrangements to begin clinical trials of its ionic silver complex technology, called Opti-Silver(TM), in pursuit of FDA drug approvals for a wide spectrum of germ-killing and tissue-regenerating applications in and on the body.
Opti-Silver(TM), a non-toxic, water-based formulation that lends itself to universal application internally and topically, has the potential to render many traditional antibiotics obsolete. The company anticipates a broad range of medical and veterinary uses.
According to Jay Newman, President of Invision International, enthusiastic reports from consumers and medical practitioners using Opti-Silver(TM) technology indicate that a revolution in the use of antibiotics may be imminent. Clinical trials are the next step in bringing about such change, which the company plans to pursue for many disease conditions. Two medical clinics in Northern California are scheduled to begin the initial human trials before the end of this year. Trials in other clinics are also being arranged.
Silver ions are known to kill virtually all bacteria that lead to all common infections. They are also believed by some to be effective against a substantial number of viruses and fungi, and to be remarkably effective at assisting the body in regenerating tissue. Ionic silver is also reputed by progressive cancer treatment centers as being highly effective against cancer, and is believed to be the primary substance used by AIDS victims on their own. Silver ions are completely harmless to mammalian cells when used in the small quantities needed to kill germs. Delivering silver ions to the body, however, is a huge challenge because they instantly bind up with other agents in the mouth or on the skin, and thereby become inert, in the absence of a controlled release system. Previous forms of ionic silver have been incapable of efficiently providing this controlled release.
Opti-Silver(TM) utilizes proprietary technology for complexing silver ions with citrate in such a way that the silver ions are released in a controlled manner upon exposure to the body's chemistry, providing a gradual release of the silver ions and facilitating the spread of the silver ions through the body. The citrate not only provides the efficiently controlled release of silver ions, but it is also an excellent internal carrier since it is a key constituent of the metabolic system and is readily drawn to the body's cells. Opti-Silver(TM), which consists of silver ions, citrate, potassium and water, is entirely safe.
